Elastography in the diagnosis of portal hypertension in patients with liver cirrhosis
- Authors: Liusina EO1, Pavlov C.S1, Ivashkin VT1
-
Affiliations:
- Первый МГМУ им. И.М. Сеченова Минздрава России
- Issue: Vol 89, No 2 (2017)
- Pages: 33-37
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/32180
- DOI: https://doi.org/10.17116/terarkh201789233-37
- ID: 32180
Cite item
Full Text
Abstract
Aim. To establish the diagnostic accuracy of liver and spleen density (LD and SD) measurements in patients with compensated alcoholic liver cirrhosis (LC) in the diagnosis of portal hypertension. Subjects and methods. The investigation enrolled 83 patients with compensated alcoholic and viral (hepatitis C virus) LC. All the patients underwent LD and SD determinations, abdominal ultrasonography, and endoscopy to detect esophageal varices (EV), as well as examination of blood indices. Results. In viral LC, there were substantial LD differences in patients with and without EV. The patients with EV were ascertained to have higher LD [27.9 (21—45) kPa] than those without EV [19.5 (16—26.2) kPa]. SD was also significantly higher than that in the EV group than in the non-EV group (p<0.001). There were no statistically significant differences in SD and LD or in spleen size in patients with alcoholic LC in relation to the presence of EV. Comparison of patients with EV of different etiology revealed differences in platelet count and spleen size. Thrombocytopenia was more pronounced in HCV-related LC patients (p=0.04). The spleen size in patients with viral LC was higher than that in those with alcoholic LC. Conclusion. Elastography of the spleen and liver may be used to identify portal hypertension in patients with viral (HCV) LC (83% sensitivity, 75% specificity) with the following threshold values: LD=26 kPa and SD=50 kPa. The threshold LD and SD values obtained for viral LC do not make possible to diagnose clinically significant portal hypertension (EV) in patients with alcoholic LC. There is a need for further investigations to determine the optimal threshold values of LD and SD for the diagnosis of EV.
Full Text
##article.viewOnOriginalSite##About the authors
E O Liusina
Первый МГМУ им. И.М. Сеченова Минздрава РоссииМосква, Россия
Ch S Pavlov
Первый МГМУ им. И.М. Сеченова Минздрава РоссииМосква, Россия
V T Ivashkin
Первый МГМУ им. И.М. Сеченова Минздрава РоссииМосква, Россия
References
- Fleming KM, Aithal GP, Solaymani-Dodaran M, Card TR West J. Incidence and prevalence of cirrhosis in the United Kingdom, 1992—2001: a general population-based study. J Hepatol. 2008; 49(5):732-738. doi: 10.1016/j.jhep.2008.05.023
- Комова А.Г. Принципы эффективной диагностики диффузных заболеваний печени на амбулаторном этапе: дис. ... канд. мед. наук. М.; 2014. 130 с.
- Pavlov CS, Casazza G, Nikolova D, Ivashkin VT, Gluud C. Systematic review with meta-analysis: diagnostic accuracy of transient elastography for staging of fibrosis in people with alcoholic liver disease. Aliment Pharmacol Ther. 2016;43(5):575-585. doi: 10.1111/apt.13524
- Ивашкин В.Т., ред. Болезни печени и желчевыводящих путей: Руководство для врачей. 2-е изд., испр. и доп. М.: Изд. Дом «М-Вести»; 2005. 536 с.
- La Mura V, Nicolini A, Tosetti G, Primignani M. Cirrhosis and portal hypertension: The importance of risk. World J. Hepatol. 2015;7(4): 688-695. doi: 10.4254/wjh.v7.i4.688
- Герок В., Блюм Х.Е. Заболевания печени и желчевыделительной системы. М.: МЕДпрессинформ; 2009. 200 с. ISBN 978-3-7945-2222-4
- Chawla YK, Bodh V. Clinical clues to the diagnosis of cirrhosis. In: Lee SS. Moreau R, eds. Cirrhosis. A practical guide to management. Wiley-Blackwell; 2-15:3-12.
- de Franchis R. on behalf of the Baveno VI Faculty, Expanding consensus in portal hypertension. J Hepatol. 2015;63(3):743-752. doi: 10.1016/j.jhep.2015.05.022
- D’Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44(1):217-231. doi: 10.1016/j.jhep.2005.10.013
- Bosch J, Abraldes JG, Berzigotti A, García-Pagan JC. The clinical use of HVPG measurements in chronic liver disease. Nat Rev Gastroenterol Hepatol. 2009;6(10):573-582. doi: 10.1038/nrgastro.2009
- Павлов Ч.С., Золотаревский В.Б., Шульпекова Ю.О., Коган Е.А., Ивашкин В.Т. Cовременные методы ранней диагностики фиброза печени. Клин. мед. 2005;83(12):58-60.
- Colecchia A, Montrone L, Scaioli E, Bacchi-Reggiani ML, Colli A, Casazza G, et al. Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis, Gastroenterology. 2012;143(3):646-654. doi: 10.1053/j.gastro.2012.05.035
- Stefanescu H, Grigorescu M, Lupsor M, Procopet B, Maniu A, Badea R. Spleen stiffness measurement using Fibroscan for the noninvasive assessment of esophageal varices in liver cirrhosis patients. J Gastroenterol Hepatol. 2011;26(1):164-170. doi: 10.3748/wjg.v20.i45.16811
- Mueller S, Seitz HK, Rausch V. Non-invasive diagnosis of alcoholic liver disease. World J Gastroenterol. 2014;20(40):14626-14641. doi: 10.3748/wjg.v20.i40.14626
![](/img/style/loading.gif)